Cordyceps vs GW-501516 for performance
Short answer: For performance, more users report improvement with Cordyceps — 98% of 41 reports, versus 93% of 71 for GW-501516.
Cordyceps has 21 meta-analyses and 32 randomized trials on PubMed; GW-501516 has 0 and 0.
Based on 363 reports about Cordyceps and 307 about GW-501516. Not medical advice.
| Cordyceps Supplement | GW-501516 Substance | |
|---|---|---|
| User score | 53 | 46 |
| Verdict | Mostly positive | Mostly positive |
| Positive of reports that state an outcome | 67% | 64% |
| Reports | 363 | 307 |
| Research | AResearch: Strong | DResearch: None |
| Meta-analyses / RCTs | 21 / 32 | 0 / 0 |
| Mainly used for | ||
| Weight loss % reporting improvement | 100% (2) | 86% (50) |
| Appetite % reporting improvement | 50% (2) | 50% (4) |
| Focus % reporting improvement | 75% (20) | — |
| Energy % reporting improvement | 88% (83) | 95% (19) |
| Sleep % reporting improvement | 43% (7) | 0% (2) |
| Anxiety % reporting improvement | 33% (6) | — |
| Mood % reporting improvement | 90% (20) | 100% (2) |
| Memory % reporting improvement | 67% (3) | — |
| Performance % reporting improvement | 98% (41) | 93% (71) |
| Recovery % reporting improvement | 100% (3) | 100% (3) |
| Pain & inflammation % reporting improvement | 100% (3) | — |
| Libido % reporting improvement | 84% (19) | — |
| Hormones % reporting improvement | 83% (12) | — |
| Heart & lipids % reporting improvement | 100% (7) | 89% (19) |
| Longevity % reporting improvement | — | 50% (2) |
| Common side effects | anxiety, insomnia, drowsiness, fatigue | cancer risk, acne, fatigue, brain fog |
| Typical dose reported | daily | 20 mg |
CordycepsFull Cordyceps profile →
Latest review conclusion
Nevertheless, the evidence is inconclusive to recommend the routine use of mushrooms for cancer patients. More trials are needed to explore mushroom use during and after cancer treatment.
Curr Oncol Rep, 2023 ↗What a user said
“I have not taken anything that has come close to the endurance and oxygen intake increase I have from Cordyceps.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate